Business Standard

Pfizer, J&J vaccines more effective against Delta variant: Experts

Delta variant, first detected in India, is driving the current third wave in South Africa

Pfizer Vaccine, Coronavirus vaccine
Premium

Photo: Shutterstock

Press Trust of India
The anti-COVID-19 vaccines by US pharma majors Pfizer and Johnson & Johnson (J&J) that are being used in South Africa are more effective against the Delta variant of the coronavirus than the Beta strain, experts have said.
 
The Beta variant, which was first detected in South Africa, caused a second wave at the beginning of this year whereas the Delta variant, first detected in India, is driving the current third wave in South Africa, resulting in increased lockdown restrictions as the number of infections and deaths have already surpassed those of the previous two waves.
 
In a media briefing led

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in